TL1A and DR3 in IBD: from mucosal immunopathology to a new era of targeted therapy.

TitleTL1A and DR3 in IBD: from mucosal immunopathology to a new era of targeted therapy.
Publication TypeJournal Article
Year of Publication2026
AuthorsLongman RS
JournalInflamm Bowel Dis
Volume32
Issue10
Pagination2072-2074
Date Published2026 Oct 01
ISSN1536-4844
DOI10.1093/ibd/izag116
Alternate JournalInflamm Bowel Dis
PubMed ID42308012
PubMed Central IDPMC13626226
Grant ListR01 DK120985 / GF / NIH HHS / United States
R01 DK120985 / DK / NIDDK NIH HHS / United States